These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 18781957)

  • 61. The role of pneumolysin in the pathogenesis of Streptococcus pneumoniae infection.
    Cockeran R; Anderson R; Feldman C
    Curr Opin Infect Dis; 2002 Jun; 15(3):235-9. PubMed ID: 12015456
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Measuring kinetic drivers of pneumolysin pore structure.
    Gilbert RJ; Sonnen AF
    Eur Biophys J; 2016 May; 45(4):365-76. PubMed ID: 26906727
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The role of pneumolysin in ocular infections with Streptococcus pneumoniae.
    Johnson MK; Hobden JA; Hagenah M; O'Callaghan RJ; Hill JM; Chen S
    Curr Eye Res; 1990 Nov; 9(11):1107-14. PubMed ID: 2095322
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Membrane perforation by the pore-forming toxin pneumolysin.
    Vögele M; Bhaskara RM; Mulvihill E; van Pee K; Yildiz Ö; Kühlbrandt W; Müller DJ; Hummer G
    Proc Natl Acad Sci U S A; 2019 Jul; 116(27):13352-13357. PubMed ID: 31209022
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Targeted small molecule inhibitors blocking the cytolytic effects of pneumolysin and homologous toxins.
    Aziz UBA; Saoud A; Bermudez M; Mieth M; Atef A; Rudolf T; Arkona C; Trenkner T; Böttcher C; Ludwig K; Hoelzemer A; Hocke AC; Wolber G; Rademann J
    Nat Commun; 2024 Apr; 15(1):3537. PubMed ID: 38670939
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Active release of pneumolysin prepores and pores by mammalian cells undergoing a Streptococcus pneumoniae attack.
    Wolfmeier H; Radecke J; Schoenauer R; Koeffel R; Babiychuk VS; Drücker P; Hathaway LJ; Mitchell TJ; Zuber B; Draeger A; Babiychuk EB
    Biochim Biophys Acta; 2016 Nov; 1860(11 Pt A):2498-2509. PubMed ID: 27481675
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Clinical Streptococcus pneumoniae isolates induce differing CXCL8 responses from human nasopharyngeal epithelial cells which are reduced by liposomes.
    Baumgartner D; Aebi S; Grandgirard D; Leib SL; Draeger A; Babiychuk E; Hathaway LJ
    BMC Microbiol; 2016 Jul; 16(1):154. PubMed ID: 27430279
    [TBL] [Abstract][Full Text] [Related]  

  • 68. How cholesterol-dependent cytolysins bite holes into membranes.
    Walz T
    Mol Cell; 2005 May; 18(4):393-4. PubMed ID: 15893721
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Identification of a secreted cholesterol-dependent cytolysin (mitilysin) from Streptococcus mitis.
    Jefferies J; Nieminen L; Kirkham LA; Johnston C; Smith A; Mitchell TJ
    J Bacteriol; 2007 Jan; 189(2):627-32. PubMed ID: 17071760
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Neutrophil-toxin interactions promote antigen delivery and mucosal clearance of Streptococcus pneumoniae.
    Matthias KA; Roche AM; Standish AJ; Shchepetov M; Weiser JN
    J Immunol; 2008 May; 180(9):6246-54. PubMed ID: 18424747
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Characterization of the solution properties and conformation of pneumolysin, the membrane-damaging toxin of Streptococcus pneumoniae.
    Morgan PJ; Varley PG; Rowe AJ; Andrew PW; Mitchell TJ
    Biochem J; 1993 Dec; 296 ( Pt 3)(Pt 3):671-4. PubMed ID: 8280065
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Pneumococcal behavior and host responses during bronchopneumonia are affected differently by the cytolytic and complement-activating activities of pneumolysin.
    Jounblat R; Kadioglu A; Mitchell TJ; Andrew PW
    Infect Immun; 2003 Apr; 71(4):1813-9. PubMed ID: 12654795
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Growth and virulence of a complement-activation-negative mutant of Streptococcus pneumoniae in the rabbit cornea.
    Johnson MK; Callegan MC; Engel LS; O'Callaghan RJ; Hill JM; Hobden JA; Boulnois GJ; Andrew PW; Mitchell TJ
    Curr Eye Res; 1995 Apr; 14(4):281-4. PubMed ID: 7606914
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Construction and immunological characterization of a novel nontoxic protective pneumolysin mutant for use in future pneumococcal vaccines.
    Kirkham LA; Kerr AR; Douce GR; Paterson GK; Dilts DA; Liu DF; Mitchell TJ
    Infect Immun; 2006 Jan; 74(1):586-93. PubMed ID: 16369015
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The autolytic enzyme LytA of Streptococcus pneumoniae is not responsible for releasing pneumolysin.
    Balachandran P; Hollingshead SK; Paton JC; Briles DE
    J Bacteriol; 2001 May; 183(10):3108-16. PubMed ID: 11325939
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Heterogeneity in pneumolysin expression governs the fate of Streptococcus pneumoniae during blood-brain barrier trafficking.
    Surve MV; Bhutda S; Datey A; Anil A; Rawat S; Pushpakaran A; Singh D; Kim KS; Chakravortty D; Banerjee A
    PLoS Pathog; 2018 Jul; 14(7):e1007168. PubMed ID: 30011336
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Red Blood Cell Susceptibility to Pneumolysin: CORRELATION WITH MEMBRANE BIOCHEMICAL AND PHYSICAL PROPERTIES.
    Bokori-Brown M; Petrov PG; Khafaji MA; Mughal MK; Naylor CE; Shore AC; Gooding KM; Casanova F; Mitchell TJ; Titball RW; Winlove CP
    J Biol Chem; 2016 May; 291(19):10210-27. PubMed ID: 26984406
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Incomplete pneumolysin oligomers form membrane pores.
    Sonnen AF; Plitzko JM; Gilbert RJ
    Open Biol; 2014 Apr; 4(4):140044. PubMed ID: 24759615
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Pyruvate oxidase of Streptococcus pneumoniae contributes to pneumolysin release.
    Bryant JC; Dabbs RC; Oswalt KL; Brown LR; Rosch JW; Seo KS; Donaldson JR; McDaniel LS; Thornton JA
    BMC Microbiol; 2016 Nov; 16(1):271. PubMed ID: 27829373
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The NLRP3 inflammasome is differentially activated by pneumolysin variants and contributes to host defense in pneumococcal pneumonia.
    Witzenrath M; Pache F; Lorenz D; Koppe U; Gutbier B; Tabeling C; Reppe K; Meixenberger K; Dorhoi A; Ma J; Holmes A; Trendelenburg G; Heimesaat MM; Bereswill S; van der Linden M; Tschopp J; Mitchell TJ; Suttorp N; Opitz B
    J Immunol; 2011 Jul; 187(1):434-40. PubMed ID: 21646297
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.